BioStem Technologies Closes Oversubscribed $2M Private Placement

BioStem Technologies Closes Oversubscribed $2M Private Placement

POMPANO BEACH, FLORIDA, November 3, 2023 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, today announces that it has...

Oncocyte to Announce Third Quarter 2023 Financial Results

Oncocyte to Announce Third Quarter 2023 Financial Results

Conference Call and Webcast on Thursday, November 9, 2023, at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, November 3, 2023 - Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, announced today that the company will host a conference call and webcast on...

PRISM MediaWire – Weekly Press Resume – Oct. 30 to Nov. 3, 2023

PRISM MediaWire – Weekly Press Resume – Oct. 30 to Nov. 3, 2023

New York, New York, Nov. 3, 2023 PRISM MediaWire - Weekly Press Resume Oct. 30 to Nov. 3, 2023 Metatron Pioneers Real-Time Stock Insights with AI-Enhanced Stock Trendz https://prismmediawire.com/metatron-pioneers-real-time-stock-insights-with-ai-enhanced-stock-trendz/...

Argentum 47, Inc. Issues Q3 2023 Letter to Shareholders

Argentum 47, Inc. Issues Q3 2023 Letter to Shareholders

Operational and Revenue Ramp Underway, Expected to Accelerate throughout 2024 WINDSOR, BERKSHIRE, UK, November 2, 2023 – Argentum 47, Inc. (OTC PINK: ARGQ), a leading provider of AI-powered digital marketing solutions including branding, advertising, and lead...

RIGHT ON BRANDS FORMS JOINT VENTURE

RIGHT ON BRANDS FORMS JOINT VENTURE

DALLAS, TX, November 2, 2023 - Right on Brands, Inc. (OTC PINK: (RTON), a fully reporting SEC filer and developer of a broad line of hemp-based and THC products, announces that it is now expanding their product line to include Nutraceuticals and Prescription-based...